---
title: Report of the sixth meeting of the European Consortium 'Care for CMMRD' (C<sub>4</sub>CMMRD),
  Paris, France, November 16th 2022
date: '2024-07-20'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39031223/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240721181857&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Biallelic germline pathogenic variants in one of the four mismatch repair
  genes (MSH2, MSH6, MLH1 and PMS2) cause a very rare, highly penetrant, childhood-onset
  cancer syndrome, called constitutional mismatch repair deficiency (CMMRD). The European
  consortium "Care for CMMRD" (C4CMMRD) was founded in Paris in 2013 to facilitate
  international collaboration and improve our knowledge of this rare cancer predisposition
  syndrome. Following initial publications on diagnostic criteria and ...
disable_comments: true
---
Biallelic germline pathogenic variants in one of the four mismatch repair genes (MSH2, MSH6, MLH1 and PMS2) cause a very rare, highly penetrant, childhood-onset cancer syndrome, called constitutional mismatch repair deficiency (CMMRD). The European consortium "Care for CMMRD" (C4CMMRD) was founded in Paris in 2013 to facilitate international collaboration and improve our knowledge of this rare cancer predisposition syndrome. Following initial publications on diagnostic criteria and ...